Warning Letter States Siemens Marketed Unapproved Diagnostic

Siemens Healthcare Diagnostics has come under FDA scrutiny after an inspection at its Tarrytown, N.Y., plant found the company was marketing a diagnostic test that had never been officially approved.
The GMP Letter